239 related articles for article (PubMed ID: 22178120)
1. Developing treatments for impaired cognition in schizophrenia.
Minzenberg MJ; Carter CS
Trends Cogn Sci; 2012 Jan; 16(1):35-42. PubMed ID: 22178120
[TBL] [Abstract][Full Text] [Related]
2. [Cognitive deficits in schizophrenia and other psychotic disorders].
Fagerlund B; Glenthøj BY
Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
[TBL] [Abstract][Full Text] [Related]
3. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cognitive deficits in schizophrenia.
Bowie CR; Harvey PD
Curr Opin Investig Drugs; 2006 Jul; 7(7):608-13. PubMed ID: 16869112
[TBL] [Abstract][Full Text] [Related]
5. Treating impaired cognition in schizophrenia.
Ibrahim HM; Tamminga CA
Curr Pharm Biotechnol; 2012 Jun; 13(8):1587-94. PubMed ID: 22283754
[TBL] [Abstract][Full Text] [Related]
6. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
Levkovitz Y; Rabany L; Harel EV; Zangen A
Int J Neuropsychopharmacol; 2011 Aug; 14(7):991-6. PubMed ID: 21524336
[TBL] [Abstract][Full Text] [Related]
7. The staging model in schizophrenia, and its clinical implications.
Agius M; Goh C; Ulhaq S; McGorry P
Psychiatr Danub; 2010 Jun; 22(2):211-20. PubMed ID: 20562749
[TBL] [Abstract][Full Text] [Related]
8. Cognitive training for divergent thinking in schizophrenia: a pilot study.
Nemoto T; Yamazawa R; Kobayashi H; Fujita N; Chino B; Fujii C; Kashima H; Rassovsky Y; Green MF; Mizuno M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1533-6. PubMed ID: 19733608
[TBL] [Abstract][Full Text] [Related]
9. The neurobiology of cognition in schizophrenia.
Tamminga CA
J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic approaches to cognitive enhancement in schizophrenia.
Burdick KE; Gopin CB; Malhotra AK
Harv Rev Psychiatry; 2011; 19(3):102-8. PubMed ID: 21631157
[TBL] [Abstract][Full Text] [Related]
11. Methods for treating cognitive deficits in schizophrenia.
Bowie CR; Jaga K
Expert Rev Neurother; 2007 Mar; 7(3):281-7. PubMed ID: 17341176
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based psychotherapy for schizophrenia.
Dickerson FB; Lehman AF
J Nerv Ment Dis; 2006 Jan; 194(1):3-9. PubMed ID: 16462548
[TBL] [Abstract][Full Text] [Related]
13. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis.
Dlabac-de Lange JJ; Knegtering R; Aleman A
J Clin Psychiatry; 2010 Apr; 71(4):411-8. PubMed ID: 20361909
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic approaches for treatment-resistant schizophrenia: a look to the future.
Miyamoto S; Jarskog LF; Fleischhacker WW
J Psychiatr Res; 2014 Nov; 58():1-6. PubMed ID: 25070124
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cognitive dysfunction in schizophrenia.
Peuskens J; Demily C; Thibaut F
Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
[TBL] [Abstract][Full Text] [Related]
16. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
Carbon M; Correll CU
CNS Spectr; 2014 Dec; 19 Suppl 1():38-52; quiz 35-7, 53. PubMed ID: 25403863
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.
Velligan DI; Miller AL
J Clin Psychiatry; 1999; 60 Suppl 23():25-8. PubMed ID: 10625197
[TBL] [Abstract][Full Text] [Related]
18. Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.
Harvey PD; Green MF; Keefe RS; Velligan DI
J Clin Psychiatry; 2004 Mar; 65(3):361-72. PubMed ID: 15096076
[TBL] [Abstract][Full Text] [Related]
19. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia.
Poulet E; Brunelin J; Bediou B; Bation R; Forgeard L; Dalery J; d'Amato T; Saoud M
Biol Psychiatry; 2005 Jan; 57(2):188-91. PubMed ID: 15652879
[TBL] [Abstract][Full Text] [Related]
20. Is there any impact of cognitive remediation on an ecological test in schizophrenia?
Royer A; Grosselin A; Bellot C; Pellet J; Billard S; Lang F; Brouillet D; Massoubre C
Cogn Neuropsychiatry; 2012; 17(1):19-35. PubMed ID: 21707472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
